Hologram Based QSAR Analysis of Caspase-3 Inhibitors

다국어 초록 (Multilingual Abstract)

Caspases, a family of cysteinyl aspartate-specific proteases plays a central role in the regulation and the execution of apoptotic cell death. Caspase-3 has been proven to be an effective target for reducing the amount of cellular and tissue damage because the activation of caspases-3 stimulates a signalling pathway that ultimately leads to the death of the cell. In this study, Hologram based Quantitative Structure Activity Relationship (HQSAR) models was generated on a series of Caspase-3 inhibitors named 3, 4-dihydropyrimidoindolones derivatives. The best HQSAR model was obtained using atoms, bonds, and hydrogen atoms (A/B/H) as fragment distinction parameter using hologram length 61 and 3 components with fragment size of minimum 5 and maximum 8. Significant cross-validated correlation coefficient ($q^2=0.684$) and non cross-validated correlation coefficients ($r^2=0.754$) were obtained. The model was then used to evaluate the eight external test compounds and its $r^2_{pred}$ was found to be 0.559. Contribution map show that presence of pyrrolidine sulfonamide ring and its bulkier substituent's makes big contributions for improving the biological activities of the compounds.

참고문헌 (Reference)

1 D. K. Perry, "Zinc is a potent inhibitor of the apoptotic protease, caspase-3. a novel target for zinc in the inhibition of apoptosis" 272 : 18530-18533, 1997

2 B. H. Han, "Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury" 277 : 30128-30136, 2002

3 J. Wang, "Roles of caspases in apoptosis, development and cytokine maturation revealed by homozygous gene deficiencies" 113 : 753-757, 2000

4 M. Thirumurthy, "QSAR analysis on PfPK7 inhibitors using HQSAR, CoMFA and CoMSIA" 21 : 681-693, 2012

5 D. V. Kravchenko, "Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-sub- stituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo [3,4-c]quinoline-1,3-diones" 40 : 1377-1383, 2005

6 M. D. Jacobson, "Pro-grammed cell death in animal development" 88 : 347-354, 1997

7 D. Lee, "Potent and selective non pep- tide inhibitors of caspase 3 and 7" 44 : 2015-2026, 2001

8 C. W. Scott, "Novel small molecule inhibitors of caspase-3 block cellular and bio-chemical features of apoptosis" 304 : 433-440, 2003

9 W. Chu, "N-Benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: Synthesis, in vitro activity and molecular modeling studies" 48 : 7637-7647, 2005

10 T. W Heritage, "Molecular Holo-gram QSAR;Rational Drug Design" American Chemical Society 719 : 212-225, 2000

11 K. M. Boatright, "Mechanisms of caspase activation" 15 : 725-731, 2003

12 J. Schoenberger, "Innovative strategies in in-vivo apoptosis imaging" 15 : 187-194, 2008

13 Sathya. B, "Homology Modelling of Chemerin like Receptor-1 (CMKLR1): Potential Target for Treating Type II Diabetes" 기초과학연구원 10 (10): 20-26, 2017

14 D. A Winkler, "Holographic QSAR of benzodiazepines" 17 : 224-231, 1998

15 Sathya Babu, "Hologram Based QSAR Analysis of Xanthine Oxidase Inhibitors" 기초과학연구원 10 (10): 202-208, 2017

16 Tripos Sybyl, "HQSAR manual"

17 W. Tong, "Evaluation of quantitative structure-activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor" 38 : 669-677, 1998

18 A. G. Porter, "Emerging roles of caspase 3 in apoptosis" 6 : 99-104, 1999

19 Sathya Babu, "Docking Study of Corticotropin-Releasing Factor-1 Receptor with Its Antagonists" 기초과학연구원 11 (11): 19-24, 2018

20 S. Wold, "Cross-validatory estimation of the num- ber of components in factor and principal component model" 20 : 397-405, 1978

21 G. M. Cohen, "Caspases: the executioners of apoptosis" 326 : 1-16, 1997

22 C. B. Thonberry, "Caspases: enemied within" 281 : 1312-1316, 1998

23 D. W. Nicolson, "Caspase structure, proteolytic substrates, and function during apoptotic cell death" 6 : 1028-1042, 1999

24 B. A. Callus, "Caspase inhibitors: viral, cellular and chemical" 14 : 73-78, 2007

25 R. S. Hotchkiss, "Caspase inhibitors improves survival in sepsis: a critical role of the lymphocyte" 1 : 496-501, 2000

26 H. Yaoita, "Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor" 97 : 276-281, 1998

27 M. Endres, "Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of caspase family" 18 : 238-247, 1998

28 C. L. Waller, "A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structur- ally diverse compounds" 44 : 758-765, 2004

29 L. M. Havran, "3.4-Dihydropyrimido (1,2-a indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3" 17 : 7755-7768, 2009